Covid Omicron JN-1 to be studied at Patanjali Research Foundation.
For the first time, a study will be conducted on the spike protein of Covid's new variant JN-1 variant. This spike protein of JN-1 variant was brought to Patanjali Research Foundation, India from Sino Biological Lab in China. Param Shradhey Acharya Balkrishna Ji is feeling immensely proud that Patanjali Research Foundation is the first research institute in India to conduct this study on this new variant, JN-1. This show that Patanjali is dedicated and passionate to ensure that research on Ayurvedic medicine is in line with the standards of modern science.
To read more in details, click the links below.